Press release
One of Scotland’s most significant scientific success stories in recent times has been celebrated at a special event hosted by the University of Dundee.
Press release
One of Scotland’s most significant scientific success stories in recent times has been celebrated at a special event hosted by the University of Dundee.
Press release
Outstanding scientific research at the University of Dundee has been honoured by Scotland’s national academy
Press release
World-leading expertise from the University of Dundee’s Centre for Targeted Protein Degradation (CeTPD) will contribute to a new, global effort to tackle some of the most significant challenges posed by cancer.
Press release
A breakthrough class of molecular glue identified at the University of Dundee could pave the way for a new generation of drugs to target cancers and neurodegenerative diseases.
Press release
University of Dundee researchers have developed a new molecule that is able to target and bind to a protein class previously considered undruggable by using a masking technique to enter the cell
News
A funding bid led by Dr Rosie Clarke will allow the School to purchase a state-of-the-art spectral flow cytometer to further enhance our research using this technology.
Press release
Researchers at the University of Dundee have received funding of £4.4 million to explore how our genes can be ‘video-edited’ to develop new drugs for cancer, neurodegeneration and other diseases.
News
Dr Will Farnaby, Principal Investigator in the Centre for Targeted Protein Degradation (CeTPD), has been awarded a Wellcome Trust Early Career Award.
Press release
A successful collaboration between the University of Dundee and pharmaceutical company Eisai Co Ltd aiming to create innovative new cancer drugs has been extended for a further three years.
Press release
An international collaboration, featuring scientists from the University of Dundee, has made a breakthrough they hope will help futureproof a revolutionary new field of drug discovery by preventing resistance in cancer therapy.
Press release
Scientists have designed a novel molecule capable of destroying an as-yet undruggable cancer-causing protein – and are making it available for researchers around the world to use in their own work, free of charge
Press release
Researchers from the University of Dundee have discovered a small molecule that helps to eliminate a Parkinson’s disease-causing protein
News
Alison McFarlane, a final year PhD student, has been awarded a 2 year Science and Business Fellowship at The Janssen Pharmaceutical Companies Of Johnson & Johnson in Leiden, Netherlands.
News
Dr Xingui Liu has been awarded a Marie Skłodowska-Curie Fellowship to undertake research in the lab of Professor Alessio Ciulli in the newly established Centre for Targeted Protein Degradation (CeTPD).
News
Amphista Therapeutics, the spin out company from the lab of Professor Alessio Ciulli, was awarded the ‘Financing Deal of the Year’ award 2021 at the Scrip Awards last month. This was in recognition of their $53M Series B funding.
News
Latest research from the lab of Dr Tony Ly describes a new proteomic analysis methodology for samples with a low cell number.
News
PhD Student Seraina Blümli and colleagues from the Owen-Hughes lab show the ARID1A subunit of the BAF chromatin remodelling complex organised nucleosomes flanking pluripotency transcription factors and association of the coactivator EP300.
Press release
Researchers from the University of Dundee and Promega Corporation have shown how a “three-headed hydra” significantly improves efficacy in a field of chemical biology that is revolutionising drug discovery.
Press release
Scientists at the University of Dundee have developed a new technology that provides a greater understanding into the biology of ‘undruggable’ diseases.
News
Collaborative research between the Universities of Dundee and Cambridge has uncovered how ‘assassin’ immune cells are able keep on killing as they hunt down cancer cells, repeatedly reloading their toxic weapons.